BioNTech (BNTX) Dips 8% In a Day: What Should You Know?

Just recently, BioNTech SE made an announcement that it is considering the building of the factories for malaria and tuberculosis vaccine production in Rwanda and Senegal cities. Looking at the chart for the last 5 days, we can see the small fall of the stock from $384.40 on August 23 to $355.70 on August 27. The decline of the BNTX is accompanied by high volatility. Future malaria and tuberculosis vaccines will be based on PNA messenger which is also used in the COVID-19 vaccine.

The company did not announce the exact date of the beginning of production yet. The CEO of the company, Ugur Sahin had approved the company intends to manufacture malaria and tuberculosis vaccines on the African continent on the meeting with Paul Kagame who is the president of Rwanda, Senegalese President Macky Sall, and Ursula von der Leyen, who is the President of European Union Commission. Also, it was implied that these sites will be located near the vaccine hubs which is planned World Health Organization (WHO). 

Agneta Johansen

Agneta is still enjoying her trips to Asia and Africa while she works at Own Snap as an author and reporter. Very soon she will settle somewhere in Europe and run her startup enterprise.